Patients with symptomatic significant (including serious) arrhythmias at 90 days and action taken where appropriate
| Ambulatory patch cohort (9 of 86=10.5%) | Historical unmatched comparator cohort (12 of 603=2.0%) |
| Symptomatic SVT with rate >100/min: initiation of antiarrhythmia medical therapy | Pause – carotid sinus sensitivity – permanent pacemaker inserted |
| Pause >6 s: permanent pacemaker inserted | Symptomatic VT |
| Pause ≥3 s (but less than 6 s) and symptomatic atrial flutter/AF with vent rate >100/min | Pause – carotid sinus sensitivity – permanent pacemaker inserted |
| Symptomatic atrial flutter/AF with vent rate >100/min | Symptomatic VT |
| Pause >6 s: permanent pacemaker inserted | Pause – carotid sinus sensitivity – permanent pacemaker inserted |
| Symptomatic atrial flutter/AF with vent rate >100/min | Pause – permanent pacemaker inserted |
| Pause >6 s: permanent pacemaker inserted | Pause – permanent pacemaker inserted |
| Complete or third degree heart block: permanent pacemaker inserted | Complete heart block – permanent pacemaker inserted |
| Non-symptomatic VT ≥120 bpm <30 s and symptomatic SVT with rate >100/min | Pause – sick sinus syndrome – permanent pacemaker inserted |
| Pause – permanent pacemaker inserted | |
| Pause – sick sinus syndrome – permanent pacemaker inserted | |
| Pause – permanent pacemaker inserted |
AF, atrial fibrillation; ST, supraventricular tachycardia; VT, ventricular tachycardia.